- Home
- CLGN vs OKYO Comparison
CLGN vs OKYO Comparison
Compare CLGN & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- OKYO
- Stock Information
- Founded
- CLGN 2004
- OKYO 2007
- Country
- CLGN Israel
- OKYO United Kingdom
- Employees
- CLGN N/A
- OKYO N/A
- Industry
- CLGN Industrial Specialties
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLGN Health Care
- OKYO Health Care
- Exchange
- CLGN Nasdaq
- OKYO Nasdaq
- Market Cap
- CLGN 44.1M
- OKYO 38.2M
- IPO Year
- CLGN N/A
- OKYO 2022
- Fundamental
- Price
- CLGN $4.19
- OKYO $1.07
- Analyst Decision
- CLGN Strong Buy
- OKYO Strong Buy
- Analyst Count
- CLGN 2
- OKYO 1
- Target Price
- CLGN $12.50
- OKYO $7.00
- AVG Volume (30 Days)
- CLGN 18.1K
- OKYO 131.4K
- Earning Date
- CLGN 11-27-2024
- OKYO 11-22-2024
- Dividend Yield
- CLGN N/A
- OKYO N/A
- EPS Growth
- CLGN N/A
- OKYO N/A
- EPS
- CLGN N/A
- OKYO N/A
- Revenue
- CLGN $689,000.00
- OKYO N/A
- Revenue This Year
- CLGN N/A
- OKYO N/A
- Revenue Next Year
- CLGN $670.03
- OKYO N/A
- P/E Ratio
- CLGN N/A
- OKYO N/A
- Revenue Growth
- CLGN N/A
- OKYO N/A
- 52 Week Low
- CLGN $3.61
- OKYO $0.81
- 52 Week High
- CLGN $6.99
- OKYO $2.12
- Technical
- Relative Strength Index (RSI)
- CLGN 51.28
- OKYO 46.47
- Support Level
- CLGN $3.61
- OKYO $1.07
- Resistance Level
- CLGN $4.39
- OKYO $1.30
- Average True Range (ATR)
- CLGN 0.23
- OKYO 0.07
- MACD
- CLGN 0.09
- OKYO -0.01
- Stochastic Oscillator
- CLGN 59.79
- OKYO 9.62
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.